<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7589781/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Principal studies evaluating the correlation between rhinovirus and severity of illness in children with bronchiolitis.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Study, 
    <br/>Year, 
    <br/>Country 
   </th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Study Design, 
    <br/>Study Population 
   </th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Period of Study Enrollment</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Age Group</th>
   <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" id="0-4-b">Sample Size 
    <br/>Number of Cases 
   </th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-6-.">Outcome—Measure of Interest</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-7-.">Results ( 
    <i>p</i>-Value) 
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Papadopoulos NG et al., 
    <br/>2002, 
    <br/>Greece 
    <br/>[ 
    <a rid="B15-microorganisms-08-01620" ref-type="bibr">15</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oct 1999–Sep 2000</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;18 month</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">118 children, 
    <br/>87 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 63/87 (72.4%) 
    <br/>- RV 25/87 (28.7%) 
    <br/>- Others 18/87 (20.7%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 16/87 (19.5%) 
    <br/>- RV + RSV 10/16 (62.5%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15-points CSI 
    <br/>based on 
    <br/>heart rate, respiratory rate, cyanosis, 
    <br/>difficult in feeding, and oxygen saturation 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RV associated with a higher CSI on admission at the univariate analysis 
    <br/>(OR 5.4; 95% CI 1.7–17.2; 
    <br/>
    <i>p</i> = 0.004) 
    <br/>and at the multivariate logistic regression analysis 
    <br/>(OR 4.9; 95% CI, 1.2–18.7; 
    <br/>
    <i>p</i> = 0.022) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Richard N, 
    <br/>2008, 
    <br/>France 
    <br/>[ 
    <a rid="B16-microorganisms-08-01620" ref-type="bibr">16</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sep 2003–Apr 2005 
    <br/>(2 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">180 infants, 
    <br/>173 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 130/173 (75.1%) 
    <br/>- RV 39/173 (22.5%) 
    <br/>- Others 36/173 (20.8%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 44/173 (25.4%) 
    <br/>- RV + RSV 13/44 (29.5%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Admission to PICU 
    <br/>
    <br/>Hospital LOS 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viral co-infections associated with an increased risk of admission to PICU 
    <br/>at the univariate analysis (OR 2.9; 95% CI 1.4–6.4) and at the multivariate logistic regression analysis 
    <br/>(OR 2.7; 95% CI, 1.2–6.2; 
    <br/>
    <i>p</i> = 0.02) 
    <br/>
    <br/>LOS tended to be prolonged in co-infection, but no statistically significant difference 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marguet C et al., 
    <br/>2009, 
    <br/>France 
    <br/>[ 
    <a rid="B17-microorganisms-08-01620" ref-type="bibr">17</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nov 2002–Mar 2004 
    <br/>(3 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">209 infants, 
    <br/>198 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 134/198 (67.7%) 
    <br/>- RV 56/198 (28.3%) 
    <br/>- Others 32/198 (16.2%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 49/198 (24.7%) 
    <br/>- RV + RSV 30/49 (61.2%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Duration of oxygen requirement 
    <br/>
    <br/>Hospital LOS &gt; 5 d 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At the multivariate logistic regression, RV infection decreased the risk to LOS &gt; 5 d compared to other viral infections, especially RSV-infection 
    <br/>(OR 0.11, 
    <br/>95% CI 0.03-0.37) 
    <br/>
    <br/>At the multivariate logistic regression, RV infection decreased the oxygen requirement compared to RSV-infections 
    <br/>(OR 0.29, 
    <br/>95% CI 0.09–0.90) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Calvo C et al., 
    <br/>2010, 
    <br/>Spain 
    <br/>[ 
    <a rid="B18-microorganisms-08-01620" ref-type="bibr">18</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sep 2005–Jul 2008</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">318 children, 
    <br/>275 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 195/275 (61.3%) 
    <br/>- RV 64/275 (17.4%) 
    <br/>- Others 109/275 (39.6%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 79/275 (28.7%) 
    <br/>N.B. frequency of RV+RSV infection not specified 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences between RV and RSV single infections, nor between co-infections and single infections</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Midulla F et al., 
    <br/>2010, 
    <br/>Italy 
    <br/>[ 
    <a rid="B19-microorganisms-08-01620" ref-type="bibr">19</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sep 2004–May 2007 
    <br/>(3 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">182 infants, 
    <br/>104 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 75/104 (72.1%) 
    <br/>- RV 16/104 (15.4%) 
    <br/>- Others 26/104 (25%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 16/104 (15.4%) 
    <br/>- RV + RSV 0 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8-points CSI based on respiratory rate, nasal flaring or chest retractions, 
    <br/>difficult in feeding, 
    <br/>arterial oxygen saturation in room air 
    <br/>
    <br/>Hospital LOS 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RV infection bronchiolitis had a lower CSI at admission than RSV infection 
    <br/>(3.00 ± 2.0 vs. 4.3 ± 2.4, 
    <br/>
    <i>p</i> = 0.05) 
    <br/>
    <br/>RV infection had a lower LOS than RSV-infection 
    <br/>(4.0 ± 1.6 d vs. 5.3 ± 2.4 d, 
    <br/>
    <i>p</i> = 0.05) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Miller EK et al., 
    <br/>2011, 
    <br/>USA 
    <br/>[ 
    <a rid="B20-microorganisms-08-01620" ref-type="bibr">20</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fall 2004–Spring 2008 
    <br/>(4 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">455 infants: 
    <br/>
    <br/>Viral types 
    <br/>- RV 81/455 (17.8%) 
    <br/>- Others 374/455 (82.2%) 
    <br/>
    <br/>Co-infections 
    <br/>- RV + other 40/455 (9%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12-points CSI based on respiratory rate, nasal flaring or chest retractions, 
    <br/>wheezing, 
    <br/>oxygen saturation in room air 
    <br/>
    <br/>Oxygen requirement 
    <br/>
    <br/>Hospital LOS 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RV infection 
    <br/>associated with a lower median CSI than infants with other viruses 
    <br/>(2.0, (IQR, 1.0–5.5) vs. 
    <br/>5.0 (IQR, 2.0–8.0), 
    <br/>
    <i>p</i> &lt; 0.001) 
    <br/>
    <br/>RV infection associated with less requirement of supplemental oxygen than infants with 
    <br/>other viral causes 
    <br/>(18% vs. 51%, 
    <i>p</i> &lt; 0.001) 
    <br/>
    <br/>No significant differences in LOS 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brand HK et al., 
    <br/>2011, 
    <br/>the Netherlands 
    <br/>[ 
    <a rid="B21-microorganisms-08-01620" ref-type="bibr">21</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nov 2006–Apr 2009 
    <br/>(3 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">142 children, 
    <br/>138 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 104/138 (75.3%) 
    <br/>- RV 43/138 (31.2%) 
    <br/>- Others 64/138 (46.4%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 58/138 (42%) 
    <br/>- RV + RSV 24/58 (41.4%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disease severity 
    <br/>3 groups: 
    <br/>mild group (no hypoxia or feeding problems), moderate group (oxygen requirement, feeding problems), 
    <br/>severe group (MV requirement) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Co-infections more frequently found in mild and moderate disease 
    <br/>than in severe disease 
    <br/>(56 and 44% respectively vs. 19%, 
    <br/>
    <i>p</i> = 0.003) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mansbach JM et al., 
    <br/>2012, 
    <br/>USA 
    <br/>[ 
    <a rid="B22-microorganisms-08-01620" ref-type="bibr">22</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter cohort study (MARC), 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nov 2007–Mar 2010 
    <br/>(3 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">2207 children, 
    <br/>2068 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- single RSV 1075/2068 (52%) 
    <br/>- single RV 167/2068 (8.1%) 
    <br/>N.B. frequency of other viral infection not specified 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 658/2068 (31.8%) 
    <br/>- RV + RSV 287/2068 (13.9%) 
    <br/>- RV + non-RSV 110/2068 (5%) 
    <br/>-RSV + non-RV 227/2068 (11%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS (cut-off ≥3 d) 
    <br/>
    <br/>PICU admission 
    <br/>
    <br/>CPAP/intubation requirement 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RV only infection or RV + non-RSV infection associated with shorter LOS than RV + RSV co-infection 
    <br/>(5% and 4% LOS ≥ 3 d 
    <br/>vs. 18% LOS ≥ 3 d, 
    <br/>
    <i>p</i> &lt; 0.001) 
    <br/>
    <br/>No significant differences in terms of PICU admission and CPAP/intubation requirement between viral groups 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ricart S et al., 
    <br/>2012, 
    <br/>Spain 
    <br/>[ 
    <a rid="B23-microorganisms-08-01620" ref-type="bibr">23</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oct 2007–Oct 2008</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">418 infants, 
    <br/>410 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 287/410 (70%) 
    <br/>- RV 125/410 (30.5%) 
    <br/>- Others 254/410 (62%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 189/410 (46.1%) 
    <br/>- RV + RSV 56/189 (24.3%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16-points CSI based on respiratory and heart rate, 
    <br/>air entrance, retractions, wheezing, oxygen saturation in room air 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RV infection associated with a severe CSI (≥11) than the other viral types at the univariate analysis 
    <br/>(39% CSI ≥ 11 
    <br/>vs. 27.7% CSI &lt; 11, 
    <br/>
    <i>p</i> = 0.041), 
    <br/>but no significant difference at the multivariate logistic regression analysis 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Miller EK et al., 
    <br/>2013, 
    <br/>USA 
    <br/>[ 
    <a rid="B24-microorganisms-08-01620" ref-type="bibr">24</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sep 2004–May 2008</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">455 infants, 
    <br/>412 virus-positive cases 
    <br/>
    <br/>Viral types 
    <br/>- RSV 268/412 (65%) 
    <br/>- RV 41/412 (10%) 
    <br/>- Others 72/412 (17.5%) 
    <br/>
    <br/>Co-infections 
    <br/>- RV + RSV 30/412 (7.3%) 
    <br/>N.B. frequency of global co-infections not specified 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12-points CSI based on respiratory rate, nasal flaring or chest retractions, wheezing, oxygen saturation in room air</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RV infection associated with lower CSI than RSV-infection 
    <br/>(median 6.5 (IQR 3.9–8) vs. median 7 (IQR 5–9), 
    <br/>
    <i>p</i> = 0.013) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chen YW et al., 
    <br/>2014, 
    <br/>Taiwan 
    <br/>[ 
    <a rid="B25-microorganisms-08-01620" ref-type="bibr">25</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jan 2009–Mar 2011</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">113 children, 
    <br/>86 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 49/86 (57%) 
    <br/>- RV 14/86 (16.3%) 
    <br/>- Others 56/86 (65.1%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 28/86 (32.6%) 
    <br/>N.B. frequency of RV+RSV infection not specified 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences among RV infections and other single and mixed infections</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jartti T et al., 
    <br/>2014, 
    <br/>Finland and USA 
    <br/>[ 
    <a rid="B26-microorganisms-08-01620" ref-type="bibr">26</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter cohort study (MARC), 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nov 2008–Mar 2010 
    <br/>(2 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">408 children, 
    <br/>350 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 144/350 (41.4%) 
    <br/>- RV 92/350 (26.3%) 
    <br/>- Others 113/350 (32.3%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 63/350 (18%) 
    <br/>- RSV + RV 10/63 (15.9%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS 
    <br/>(2 groups: &lt;3 d 
    <br/>and ≥3d) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Overall RV infection associated with shorter hospital LOS compared to RSV-infection 
    <br/>(adjusted OR 0.45, 
    <br/>95% CI 0.22–0.92, 
    <br/>
    <i>p</i> = 0.03) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mehta R et al., 
    <br/>2014, 
    <br/>USA 
    <br/>[ 
    <a rid="B27-microorganisms-08-01620" ref-type="bibr">27</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective cross-sectional single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oct 2010–Apr 2011</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">131 children, 
    <br/>120 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 84/120 (70%) 
    <br/>- RV 34/120 (28.3%) 
    <br/>- Others 37/120 (30.8%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 39/120 (32.5%) 
    <br/>- RV + RSV 18/39 (46.2%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Admission to PICU</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences between types of viral infection about admission to PICU</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Selvaggi C et al., 
    <br/>2014, 
    <br/>Italy 
    <br/>[ 
    <a rid="B28-microorganisms-08-01620" ref-type="bibr">28</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008–2011 
    <br/>(3 epidemic seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">250 infants, 
    <br/>118 single RV or RSV-infection 
    <br/>
    <br/>Viral types 
    <br/>- RSV 78/118 (66.1%) 
    <br/>- RV 40/118 (33.9%) 
    <br/>- RV-A 18/40 (45%) 
    <br/>- RV-C 22/40 (55%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences in term of LOS between RV infection, RV types, and RSV bronchiolitis</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jartti et al., 
    <br/>2015, 
    <br/>Finland and USA 
    <br/>[ 
    <a rid="B29-microorganisms-08-01620" ref-type="bibr">29</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter cohort study (MARC), 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis with a focus on RV genomic viral load 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007–2010 
    <br/>(4 winter seasons, USA) 
    <br/>
    <br/>2008–2010 
    <br/>(3 winter seasons, Finland) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">2615 children, 
    <br/>694 with RV detection 
    <br/>
    <br/>Viral types 
    <br/>- RV 694/2615 (26.5%) 
    <br/>- RV only 259/694 (37.3%) 
    <br/>
    <br/>Co-infections 
    <br/>- RV + RSV 297/694 (43%) 
    <br/>- RV + non RSV 138/694 (20%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS (cut-off ≥3 d) 
    <br/>
    <br/>PICU admission 
    <br/>
    <br/>CPAP/intubation requirement 
    <br/>
    <br/>N.B. analyzed outcomes after classification of RV genomic load into 3 groups (low, intermediate, high) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant association between RV genomic load, nor co-infection, and LOS ≥ 3 days or risk of PICU admission or CPAP/intubation requirement in unadjusted and multivariable models</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cangiano G et al., 
    <br/>2016, 
    <br/>Italy 
    <br/>[ 
    <a rid="B30-microorganisms-08-01620" ref-type="bibr">30</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oct 2004–Mar 2014 
    <br/>(10 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">723 infants, 
    <br/>351 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 234/351 (66.7%) 
    <br/>- RV 44/351 (12.5%) 
    <br/>- Others 34/351 (9.7%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 39/351 (11.1%) 
    <br/>- RV + RSV 14/39 (35.9%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8-points CSI based on respiratory rate, chest retractions, difficult in feeding, arterial oxygen saturation on room air 
    <br/>
    <br/>Hospital LOS 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences in terms of clinical severity score and LOS between different viruses’ group, including co-infected infants</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skjerven HO et al., 
    <br/>2016, 
    <br/>Norway 
    <br/>[ 
    <a rid="B31-microorganisms-08-01620" ref-type="bibr">31</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter, 
    <br/>hospitalized children with a clinical diagnosis of moderate-severe bronchiolitis based on a 10-points CSI 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jan 2010–May 2011 
    <br/>(2 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">363 infants, 
    <br/>330 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 300/330 (90.9%) 
    <br/>- RV 122/330 (37%) 
    <br/>- RV A/B 35/122 (28.7%) 
    <br/>- RV C 87/122 (71.3%) 
    <br/>- Others 314/330 (95.2%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect 223/330 (67.6%) 
    <br/>- RV + RSV 105/233 (45%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS 
    <br/>
    <br/>Level of supportive care (3 groups: 
    <br/>no supportive care, use of oxygen and/or nasogastric tube feeding, 
    <br/>use of ventilatory support) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences in terms of LOS nor level of supportive care between RV infection, RV types, other single virus-infections, RV + RSV infections, other co-infections</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paul SP et al., 
    <br/>2017, 
    <br/>UK 
    <br/>[ 
    <a rid="B32-microorganisms-08-01620" ref-type="bibr">32</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apr 2012–Dec 2015</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">319 children, 
    <br/>227 single RV or RSV-infection 
    <br/>
    <br/>Viral types 
    <br/>- RSV 162/227 (71.4%) 
    <br/>- RV 65/227 (28.6%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RV infection associated with a longer hospital LOS than RSV-infection 
    <br/>(4.6 d (range 0–21 d) vs. 3.2 d (range 0–13 d), 
    <br/>
    <i>p</i> = 0.032) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Garcìa-Garcìa ML et al., 
    <br/>2017, 
    <br/>Spain 
    <br/>[ 
    <a rid="B33-microorganisms-08-01620" ref-type="bibr">33</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective cross-sectional single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oct 2013–Apr 2016</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">213 hospitalized children vs. 45 healthy controls, 
    <br/>186 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 149/186 (80.1%) 
    <br/>- RV 42/186 (22.6%) 
    <br/>- Others 42/186 (22.6%) 
    <br/>
    <br/>N.B. frequency of co-infections nor RV + RSV infection not specified 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences among RV bronchiolitis and RSV-bronchiolitis</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Petrarca L et al., 
    <br/>2018, 
    <br/>Italy 
    <br/>[ 
    <a rid="B34-microorganisms-08-01620" ref-type="bibr">34</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oct 2004–May 2016 
    <br/>(12 winter seasons) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">486 virus-positive infants: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 365/486 (75.1%) 
    <br/>- RV 89/486 (18.3%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 54/486 (11.1%) 
    <br/>- RV + RSV 20/54 (37%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8-points CSI based on respiratory rate, nasal flaring or chest retractions, 
    <br/>difficult in feeding, 
    <br/>arterial oxygen saturation in room air 
    <br/>
    <br/>PICU admission 
    <br/>
    <br/>Hospital LOS 
    <br/>
    <br/>Oxygen requirement 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences about clinical severity score, PICU admission, LOS, oxygen requirement between RSV-infection, RV infection, RV + RSV infection</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Praznik A et al., 
    <br/>2018, 
    <br/>Slovenia 
    <br/>[ 
    <a rid="B35-microorganisms-08-01620" ref-type="bibr">35</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective single-center, 
    <br/>children with a clinical diagnosis of bronchiolitis with focus on the need for hospitalization (stratification in 3 groups of patients: outpatients with no hospitalization, standard hospitalization, admission to PICU) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">May 2014–Apr 2015</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">761 children, 
    <br/>473 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 272/473 (57.5%) 
    <br/>- RV 121/473 (25.6%) 
    <br/>- Others 87/473 (18.4%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 151/473 (31.9%) 
    <br/>N.B. frequency of RV+RSV infection not specified 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disease severity classified according to the site management 
    <br/>(3 groups: outpatients, standard hospital, PICU) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences between types of viral infection about patient’s site management</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bergroth E et al., 
    <br/>2019, 
    <br/>Finland 
    <br/>[ 
    <a rid="B36-microorganisms-08-01620" ref-type="bibr">36</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter cohort study (MARC-30), 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis with follow-up 4 years after discharge 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nov 2008–Mar 2010</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">349 children, 
    <br/>302 virus-positive cases: 
    <br/>
    <br/>Viral types and RV types 
    <br/>- RSV 145/302 (48%) 
    <br/>- RV 101/302 (33.4%) 
    <br/>- RV-A 24/101 (23.8%) 
    <br/>- RV-B 3/101 (3%) 
    <br/>- RV-C 73/101 (72.3%) 
    <br/>- Others 51/302 (16.9%) 
    <br/>
    <br/>Co-infections 
    <br/>- RSV + RV 8/302 (2.6%) 
    <br/>N.B. frequency of co-infections not specified 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS 
    <br/>(cut-off ≥ 3 d) 
    <br/>
    <br/>Admission to PICU 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RV-A and RV-C infection associated with lower LOS than RSV-infection 
    <br/>(25% and 19% vs. 41%, 
    <br/>
    <i>p</i> = 0.003) 
    <br/>
    <br/>RV infection associated with lower admission to PICU than RSV-infection 
    <br/>(0 vs. 9%, 
    <br/>
    <i>p</i> = 0.02) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hasegawa K et al., 
    <br/>2019, 
    <br/>Finland and USA 
    <br/>[ 
    <a rid="B37-microorganisms-08-01620" ref-type="bibr">37</a>] 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter cohort study 
    <br/>(MARC-30, Finland and MARC-35 USA), 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis with a focus on RVspecies 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008–2010 
    <br/>(2 winter seasons, Finland) 
    <br/>
    <br/>Nov 2011–Apr 2014 
    <br/>(3 winter seasons, USA) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MARC-30 Finland 
    <br/>
    <br/>408 infants, 
    <br/>109 RVinfection 
    <br/>
    <br/>RV types 
    <br/>RV-A (23%) 
    <br/>RV-B (3%) 
    <br/>RV-C (74%) 
    <br/>
    <br/>Co-infections 
    <br/>RV + RSV (7%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MARC-35 USA 
    <br/>
    <br/>1016 infants, 197 RVinfection 
    <br/>
    <br/>RV types 
    <br/>RV-A (47%) 
    <br/>RV-B (6%) 
    <br/>RV-C (47%) 
    <br/>
    <br/>Co-infections 
    <br/>RV + RSV (56%) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital LOS 
    <br/>
    <br/>PICU admission 
    <br/>
    <br/>CPAP/intubation requirement 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences in terms of LOS, PICU admission, and CPAP/intubation requirement between the 3 different RV types</td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>CI = confidence interval; CPAP = continuous positive airway pressure; CSI = clinical score index; d = day; LOS = length of stay; MARC = Multicenter Airway Research Collaboration; mo = month; MV = mechanical ventilation; OR = odds ratio; PICU = Pediatric Intensive Care Unit; RSV = respiratory syncytial virus; RV = rhinovirus; y = year.</p>
  </p>
 </tfoot>
</table>
